Heart failure is characterised by contractile dysfunction caused by a decreased sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) activity. In September 18
del Monte
"This study validates the feasibility of cardiac gene transfer in failing hearts as a therapeutic modality," said the authors.